Avera Health partners with Elekta to deliver most advanced cancer care

ATLANTA, December 4, 2014 – To provide high-quality, evidence-based cancer care
throughout South Dakota, Minnesota and other surrounding states, Avera Health
and Elekta (EKTA-B.ST) announce a partnership to deploy
MOSAIQ® (http://www.elekta.com/healthcare-professionals/products/elekta
-software/radiation-oncology.html) oncology information system across the Avera
Cancer Institute.
This partnership will enable Avera to implement an integrated oncology health
system that spans the full cancer care continuum, from prevention and screening
through to palliation and recovery.

The agreement includes Elekta linear accelerators (Versa
HD™ (http://www.versahd.com/), Elekta
Infinity™ (http://www.elekta.com/healthcare-professionals/products/elekta
-oncology/oncology-treatment-solutions/elekta-infinity.html)), Leksell Gamma
Knife® Perfexion™ (http://www.elekta.com/healthcare
-professionals/products/elekta-neuroscience/gamma-knife-surgery/gamma-knife
-perfexion.html), brachytherapy solutions (http://www.elekta.com/healthcare
-professionals/products/elekta
-brachytherapy.html?utm_source=brachytherapy&utm_medium=redirect&utm_campaign=re
d 
irects), Monaco® (http://www.elekta.com/healthcare-professionals/products/elekta
-software/treatment-planning-software/planning
-software/monaco.html?utm_source=monaco&utm_medium=redirect&utm_campaign=redirec
t 
s) treatment planning and METRIQ™ (http://www.elekta.com/healthcare
-professionals/products/elekta-software/cancer-registry.html) cancer registry
software. All of the software will be deployed through a cloud-based solution.

“Being chosen by comprehensive cancer networks, such as Avera Health, further
demonstrates Elekta’s leadership in oncology information systems,” says Jay
Hoey, Elekta’s Executive Vice President of Region North America. “We are excited
to be collaborating with this leader in cancer therapy.”

Dave Kapaska, DO, Regional President and CEO of Avera McKennan Hospital &
University Health Center and administrative leader of the Avera Health cancer
service line, says: “The Avera cancer service line is dedicated to providing
research-based, technologically advanced, world-class care, wherever our
patients and their families are located. This partnership will assist us to
fulfill this vision by ensuring consistent high quality care across all Avera
Cancer Institute locations. We are thrilled to have found a partner that shares
our vision for integrated quality care.”

Dave Flicek, Chief Administrative Officer for Avera Medical Group, says:
“Through this partnership, Avera will be able to access a single patient record
at any of our cancer centers and outreach locations. This ensures connectivity
between cancer providers, chemotherapy and radiation therapy centers and cancer
registries, as we offer our patients the highest level of cancer care in the
region.”

“By choosing Elekta as our partner, we will be able to give our patients access
to the world’s most advanced technology for treating cancer,” says Michael
Peterson, MD, Radiation Oncologist with Avera Health. “Having both Versa HD and
Perfexion provides superior capabilities for stereotactic treatment delivery,
enabling us to perform treatments faster, with even greater precision.”

Cancer is the second leading cause of death in the United States and South
Dakota,* which has a population of about 850,000. The agreement will benefit
Avera’s six regional locations and 40 outreach sites by driving further
improvements in quality patient care.

More than USD 20 million of the agreement was booked during Elekta’s second
fiscal quarter.

*2012, South Dakota Department of Health, Vital Statistics

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on December 4, 2014.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.

About Avera Health
Avera, the health ministry of the Benedictine and Presentation Sisters, is a
regional partnership of health professionals who share support services to
maintain excellent care at more than 300 locations in eastern South Dakota and
surrounding states.

Avera caregivers are supported by the resources and expertise of the region's
largest health system. Management and other support services are provided
through the Avera Central Office in Sioux Falls, S. D., and its five regional
centers: Avera St. Luke's Hospital in Aberdeen, S.D.; Avera Queen of Peace
Hospital in Mitchell, S.D.; Avera McKennan Hospital & University Health Center
in Sioux Falls, S.D.; Avera Sacred Heart Hospital in Yankton, S.D.; and Avera
Marshall Regional Medical Center in Marshall, Minn. More information at
www.Avera.org